Myrianthopoulos, V.; Lozach, O.; Zareifi, D.; Alexopoulos, L.; Meijer, L.; Gorgoulis, V.G.; Mikros, E.
Combined Virtual and Experimental Screening for CK1 Inhibitors Identifies a Modulator of p53 and Reveals Important Aspects of in Silico Screening Performance. Int. J. Mol. Sci. 2017, 18, 2102.
https://doi.org/10.3390/ijms18102102
AMA Style
Myrianthopoulos V, Lozach O, Zareifi D, Alexopoulos L, Meijer L, Gorgoulis VG, Mikros E.
Combined Virtual and Experimental Screening for CK1 Inhibitors Identifies a Modulator of p53 and Reveals Important Aspects of in Silico Screening Performance. International Journal of Molecular Sciences. 2017; 18(10):2102.
https://doi.org/10.3390/ijms18102102
Chicago/Turabian Style
Myrianthopoulos, Vassilios, Olivier Lozach, Danae Zareifi, Leonidas Alexopoulos, Laurent Meijer, Vassilis G. Gorgoulis, and Emmanuel Mikros.
2017. "Combined Virtual and Experimental Screening for CK1 Inhibitors Identifies a Modulator of p53 and Reveals Important Aspects of in Silico Screening Performance" International Journal of Molecular Sciences 18, no. 10: 2102.
https://doi.org/10.3390/ijms18102102
APA Style
Myrianthopoulos, V., Lozach, O., Zareifi, D., Alexopoulos, L., Meijer, L., Gorgoulis, V. G., & Mikros, E.
(2017). Combined Virtual and Experimental Screening for CK1 Inhibitors Identifies a Modulator of p53 and Reveals Important Aspects of in Silico Screening Performance. International Journal of Molecular Sciences, 18(10), 2102.
https://doi.org/10.3390/ijms18102102